Cancer Therapies Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Global

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Biotechnology > Agriculture > Cancer Therapies Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Cancer Therapies Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Cancer therapies are drugs that are actively involved in reducing or blocking the growth of cancer by interacting with specific molecules which are responsible for the increase, progression, and spread of cancerous cells. Cancer therapy is different from standard chemotherapy treatment as these therapies target only cancerous cells without affecting the healthy cells. Cancer therapies market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and cancer types. Many industries and firms are trying to develop new technologies and make advancements to improve the market.

Cancer Therapies Market Segments size & growth:

The market is valued at USD XX million in2017 and is expected to reach USD XX million by 2024 at a CAGR of XX%. The cancer therapies market growth is mainly due to rise in cancer incidences and access to modern therapeutics, the population of aged people, efficiency and high price manufacturers and innovations and increases in awareness regarding molecular diagnostic techniques. These

Cancer Therapies Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

are the significant factors influencing the market growth.

Cancer Therapies Market Segment share:

Cancer therapies Market is segmented into treatment type, cancer type, therapeutics, application, and chemotherapy. Targeted cancer is holding the most significant share in the market due to the increasing prevalence of various types of cancers and awareness regarding the molecular diagnostics. By treatment type, the market is in surgery, chemotherapy, radiation therapy, targeted therapy, immune therapy, hormonal therapy, hyperthermia and stem cell transplant. By cancer type, the market is in blood therapy, bone cancer, brain cancer, breast cancer, endocrine cancer, eye cancer, gynecologic cancer, head and neck cancer, respiratory and skin cancer. By application, the market is into Nasal spray, pills or tablets, skin gel, skin patches, vaginal creams or vaginal tablets and vaginal ring. On the basis chemotherapy, type of agents and chemotherapy regimens are the segments. Geographically, North America is occupying the most significant share in the market, especially in globally targeted therapies demand due to more number of market players and higher patient

You can also purchase parts of this report. Do you want to check out a section wise price list

Cancer Therapies Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

awareness levels.

Cancer Therapies Market Trends:

Genentech signed an agreement to acquire tanox a biotechnology company.
Genentech and tanox are trying to collaborate with Novartis to develop and commercialise Xolair and anti-IgE monoclonal antibody.
Roche and Genentech announced the acquisition of Genentech and Genentech became a wholly owned member of Roche group.

Cancer Therapies Market Research Reports Include:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The principal market players are:
Novartis
Astrazeneca Plc
Genentech Inc.
Chugai pharmaceutical co Ltd
GlaxoSmithKline PLC

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.